REG - Acceler8 Ventures - Results of CLN fundraise

Acceler8 VenturesAnnouncement

21/04/2026 07:00

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20260421:nRSU2076Ba&default-theme=true

RNS Number : 2076B  Acceler8 Ventures PLC  21 April 2026

21 April 2026

ACCELER8 VENTURES PLC

Results of CLN fundraise

Acceler8 Ventures Plc (LSE: AC8, "AC8" or the "Company"), the Main Market
listed acquisition company, announces that, further to the announcement made
on 8 April 2026 ("CLN Announcement"), AC8 has successfully secured funding
commitments of £1,000,000 through the proposed issue of unsecured Convertible
Loan Notes ("2026 CLNs").

The 2026 CLNs will be issued to incoming investors, in accordance with the
terms set out in the CLN Announcement, with the proceeds from the 2026 CLNs to
be used to support the Company's near term working capital requirements, as
described in the CLN Announcement.

The issuance of the 2026 CLNs remains conditional on approval by shareholders
of the Company of the requisite resolutions at a general meeting of the
Company, as set out in the CLN Announcement.

Enquiries:

 

 Acceler8 Ventures Plc                  David Williams  C/o Tessera Investment Management Limited

 Tessera Investment Management Limited  Tony Morris     Tel: 07742 189145

Katie Long
 (Financial Adviser to AC8)
James Strang

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  ROIURSKRNOUSUAR



            Copyright 2019 Regulatory News Service, all rights reserved